21-Dehydrocorticosterone (mixture of the aldehyde and the hydrated form) |
D229160 |
Toronto Research Chemicals |
250mg |
EUR 230 |
|
Description: 20287-97-2 |
Human IgG antibody Laboratories manufactures the rbd of the spike domain reagents distributed by Genprice. The Rbd Of The Spike Domain reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Domain. Other Rbd products are available in stock. Specificity: Rbd Category: Of Group: The Spike
The metabolite of Nitrofurantoin Antibody |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
The metabolite of furaltadone Antibody |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
The metabolite of nitrofurazone Antibody |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
The metabolite of furazolidone Antibody |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
The metabolite of furaltadone Antibody |
Abbexa |
100 µl |
EUR 400 |
The metabolite of furaltadone Antibody |
Abbexa |
50 µl |
EUR 281.25 |
The metabolite of nitrofurazone Antibody |
Abbexa |
100 µl |
EUR 400 |
The Spike information
2019 nCoV/COVID19 RBD domain of spike recombinant protein (S), Biotinylated |
BSV-COV-PR-46 |
BioServUK |
100 ug |
EUR 1517 |
Description: 2019 nCoV/COVID19 RBD domain of spike recombinant protein (S), Biotinylated (100 ug) |
2019 nCoV/COVID19 RBD domain of spike recombinant protein (S), Biotinylated |
BSV-COV-PR-47 |
BioServUK |
500 ug |
EUR 2781 |
Description: 2019 nCoV/COVID19 RBD domain of spike recombinant protein (S), Biotinylated (500 ug) |
Mouse Anti SARS-CoV-2 Spike (S1) RBD Antibody (DH6): HRP Conjugate |
MAB12444-HRP-100 |
The Native Antigen Company |
0.1 |
EUR 585.57 |
Description: Purified monoclonal antibody conjugated to Horseradish Peoxidase (HRP). Antibody is neutralising against SARS-CoV-2, but not against SARS-CoV-1 or MERS-CoV. |
SARS-CoV-2 (N501Y Mutant) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31946-100 |
The Native Antigen Company |
0.1 |
EUR 419.73 |
Description: SARS-CoV-2 Spike S1 RBD (AA1-223), carrying the N501Y amino acid change. This change is present in all three major global SARS-CoV-2 variants: B.1.1.7, B.1.1.28 and B.1.351. The protein was produced in HEK293 cells and purified from culture supernanant. |
SARS-CoV-2 (N501Y Mutant) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31946-500 |
The Native Antigen Company |
0.5 |
EUR 1599.79 |
Description: SARS-CoV-2 Spike S1 RBD (AA1-223), carrying the N501Y amino acid change. This change is present in all three major global SARS-CoV-2 variants: B.1.1.7, B.1.1.28 and B.1.351. The protein was produced in HEK293 cells and purified from culture supernanant. |
SARS-CoV-2 Spike Glycoprotein (S1) RBD, His-Tag (HEK293): Biotin Conjugate |
REC31882-Biotin-100 |
The Native Antigen Company |
0.1 |
EUR 501.38 |
Description: SARS-CoV-2 Spike protein receptor binding domain (RBD) produced in HEK293 cells. The protein was purified from culture supernatant by immobilised metal affinity chromatography and conjugated to biotin. |
SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC32007-100 |
The Native Antigen Company |
0.1 |
EUR 419.73 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike receptor binding domain protein. Relative to Wuhan-Hu-1 this protein has following amino acid changes: G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H. |
SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC32007-500 |
The Native Antigen Company |
0.5 |
EUR 1599.79 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike receptor binding domain protein. Relative to Wuhan-Hu-1 this protein has following amino acid changes: G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H. |
SARS-CoV-2 (COVID-19) Spike RBD domain Recombinant Protein |
20-232 |
ProSci |
0.1 mg |
EUR 726.9 |
Description: SARS-CoV-2 (COVID-19) Spike RBD domain Recombinant Protein |
SARS-CoV-2 Spike B.1.617 Mutation RBD Domain (Indian Variant, 100ug) |
BSV-COV-PR-96 |
BioServUK |
100 ug |
EUR 620 |
Description: SARS-CoV-2 Spike B.1.617 Mutation RBD Domain (Indian Variant, 100ug) |
SARS-CoV-2 (B.1.617.1: E484Q, L452R) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31971-100 |
The Native Antigen Company |
0.1 |
EUR 419.73 |
Description: SARS-CoV-2 B.1.617.1 (Kerala variant) receptor binding domain (E484Q, L452R amino acid changes relative to Wuhan-Hu-1). |
SARS-CoV-2 (B.1.617.1: E484Q, L452R) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31971-500 |
The Native Antigen Company |
0.5 |
EUR 1599.79 |
Description: SARS-CoV-2 B.1.617.1 (Kerala variant) receptor binding domain (E484Q, L452R amino acid changes relative to Wuhan-Hu-1). |
SARS-CoV-2 (B.1.617.2; L452R, T478K) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31974-100 |
The Native Antigen Company |
0.1 |
EUR 419.73 |
Description: SARS-CoV-2 receptor binding domain with the two amino acid changes L452R and T478K relative to Wuhan-Hu-1 full length Spike protein. |
SARS-CoV-2 (B.1.617.2; L452R, T478K) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31974-500 |
The Native Antigen Company |
0.5 |
EUR 1599.79 |
Description: SARS-CoV-2 receptor binding domain with the two amino acid changes L452R and T478K relative to Wuhan-Hu-1 full length Spike protein. |
SARS-CoV-2 (501Y.V2: K417N, E484K, N501Y) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31945-100 |
The Native Antigen Company |
0.1 |
EUR 419.73 |
Description: SARS-CoV-2 Spike receptor binding domain RBD. Contains amino acid changes K417N, E484K, N501Y relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant. |
SARS-CoV-2 (501Y.V2: K417N, E484K, N501Y) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) |
REC31945-500 |
The Native Antigen Company |
0.5 |
EUR 1599.79 |
Description: SARS-CoV-2 Spike receptor binding domain RBD. Contains amino acid changes K417N, E484K, N501Y relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant. |
SARS-CoV-2 Spike B.1.1.7 Mutation RBD Domain (UK Variant, 100ug) |
BSV-COV-PR-72 |
BioServUK |
100 ug |
EUR 620 |
Description: SARS-CoV-2 Spike B.1.1.7 Mutation RBD Domain (UK Variant, 100ug) |